Przyklenk K, Kloner R A
Department of Internal Medicine, Harper Hospital, Detroit, Michigan.
Circ Res. 1989 Jan;64(1):86-96. doi: 10.1161/01.res.64.1.86.
Do oxygen-derived free radicals, generated at the time of reperfusion, lethally injure viable, previously ischemic myocardium, damage vascular endothelium, and impair recovery of postischemic contractile function? To address these issues, 23 anesthetized open-chest dogs underwent 2 hours of left anterior descending coronary artery occlusion followed by 4 hours of reperfusion. Immediately prior to reflow, each dog was randomized to receive either the free radical scavenging agents superoxide dismutase (SOD) + catalase, or saline alone. SOD + catalase had no significant beneficial effect on infarct size measured by triphenyltetrazolium staining: area of necrosis averaged 38.5 +/- 6.1% vs. 46.3 +/- 6.2% of the area at risk in treated compared with control animals respectively (p = NS). Furthermore, infusion of SOD + catalase did not alter contractile function of the viable subepicardium: mean segment shortening (measured using sonomicrometry) at 4 hours postreperfusion was -23 +/- 5% of baseline, preocclusion values in controls dogs and -24 +/- 9% of preocclusion values in animals that received the scavenging agents. However, SOD + catalase treatment preserved the endocardial microvasculature (assessed by semiquantitative electron microscopic analysis) and enhanced regional myocardial blood flow after reperfusion. Specifically, mean score for microvascular injury was 0.41 +/- 0.14 vs. 0.10 +/- 0.08 (p less than 0.05) in control compared with SOD + catalase treated groups, and blood flow averaged 0.56 +/- 0.11 vs. 1.27 +/- 0.33 ml/min/g tissue (p less than 0.05), respectively, in the previously ischemic endocardium at 2 hours postreflow. Thus, SOD + catalase given at the time of reperfusion had no acute beneficial effect on either the extent of myocyte necrosis or postischemic contractile function in this canine model. SOD + catalase did, however, attenuate both endocardial vascular injury and the "low reflow" phenomenon. These data suggest that microvascular injury and low reflow following prolonged (2 hour) but transient coronary occlusion may be mediated by oxygen-derived free radicals generated at the time of reperfusion.
再灌注时产生的氧衍生自由基是否会对存活的、先前缺血的心肌造成致命损伤,损害血管内皮,并损害缺血后收缩功能的恢复?为了解决这些问题,对23只麻醉开胸犬进行了2小时的左前降支冠状动脉闭塞,随后进行4小时的再灌注。在再灌注前,每只犬被随机分为接受自由基清除剂超氧化物歧化酶(SOD)+过氧化氢酶或仅接受生理盐水。通过三苯基四氮唑染色测量,SOD +过氧化氢酶对梗死面积没有显著的有益影响:与对照动物相比,治疗组坏死面积平均分别为危险区面积的38.5±6.1%和46.3±6.2%(p =无显著性差异)。此外,输注SOD +过氧化氢酶并没有改变存活的心外膜下心肌的收缩功能:再灌注后4小时,对照犬的平均节段缩短(使用超声心动图测量)为基线、闭塞前值的-23±5%,接受清除剂的动物为闭塞前值的-24±9%。然而,SOD +过氧化氢酶治疗保留了心内膜微血管(通过半定量电子显微镜分析评估),并增强了再灌注后的局部心肌血流。具体而言,与SOD +过氧化氢酶治疗组相比,对照组微血管损伤的平均评分为0.41±0.14 vs. 0.10±0.08(p<0.05),再灌注后2小时,先前缺血的心内膜的血流平均分别为0.56±0.11 vs. 1.27±0.33 ml/min/g组织(p<0.05)。因此,在再灌注时给予SOD +过氧化氢酶对该犬模型中的心肌细胞坏死程度或缺血后收缩功能均无急性有益作用。然而,SOD +过氧化氢酶确实减轻了心内膜血管损伤和“低再灌注”现象。这些数据表明,长时间(2小时)但短暂冠状动脉闭塞后的微血管损伤和低再灌注可能是由再灌注时产生的氧衍生自由基介导的。